Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2016 2
2017 4
2018 2
2019 2
2020 4
2021 8
2022 8
2023 9
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

37 results

Results by year

Filters applied: . Clear all
Page 1
Real-World Data on Clinical Outcomes and Treatment Management of Advanced Melanoma Patients: Single-Center Study of a Tertiary Cancer Center in Switzerland.
Staeger R, Martínez-Gómez JM, Turko P, Ramelyte E, Kraehenbuehl L, Del Prete V, Hasan Ali O, Levesque MP, Dummer R, Nägeli MC, Mangana J. Staeger R, et al. Among authors: ramelyte e. Cancers (Basel). 2024 Feb 20;16(5):854. doi: 10.3390/cancers16050854. Cancers (Basel). 2024. PMID: 38473216 Free PMC article.
The genetic evolution of acral melanoma.
Wang M, Fukushima S, Sheen YS, Ramelyte E, Pacheco NC, Shi C, Liu S, Banik I, Aquino JD, Acosta MS, Levesque M, Dummer R, Liau JY, Chu CY, Shain AH, Yeh I, Bastian BC. Wang M, et al. Among authors: ramelyte e. bioRxiv [Preprint]. 2023 Oct 19:2023.10.18.562802. doi: 10.1101/2023.10.18.562802. bioRxiv. 2023. PMID: 37904969 Free PMC article. Preprint.
The role of diabetes in metastatic melanoma patients treated with nivolumab plus relatlimab.
Mallardo D, Woodford R, Menzies AM, Zimmer L, Williamson A, Ramelyte E, Dimitriou F, Wicky A, Wallace R, Mallardo M, Cortellini A, Budillon A, Atkinson V, Sandhu S, Olivier M, Dummer R, Lorigan P, Schadendorf D, Long GV, Simeone E, Ascierto PA. Mallardo D, et al. Among authors: ramelyte e. J Transl Med. 2023 Oct 25;21(1):753. doi: 10.1186/s12967-023-04607-4. J Transl Med. 2023. PMID: 37880788 Free PMC article.
What Is New in Cutaneous T Cell Lymphoma?
Morgenroth S, Roggo A, Pawlik L, Dummer R, Ramelyte E. Morgenroth S, et al. Among authors: ramelyte e. Curr Oncol Rep. 2023 Nov;25(11):1397-1408. doi: 10.1007/s11912-023-01464-8. Epub 2023 Oct 24. Curr Oncol Rep. 2023. PMID: 37874473 Free PMC article. Review.
The role of triple therapy and therapy sequence in treatment of BRAF-mutant metastatic melanoma. Response to overall survival with first-line atezolizumab in combination with vemurafenib and cobimetinib in BRAFV600 mutation-positive advanced melanoma (IMspire150): second interim analysis of a multicentre, randomised, phase 3 study.
Dummer R, Welti M, Ramelyte E. Dummer R, et al. Among authors: ramelyte e. J Transl Med. 2023 Aug 5;21(1):529. doi: 10.1186/s12967-023-04391-1. J Transl Med. 2023. PMID: 37543586 Free PMC article. Clinical Trial.
Tebentafusp in Patients with Metastatic Uveal Melanoma: A Real-Life Retrospective Multicenter Study.
Tomsitz D, Ruf T, Heppt M, Staeger R, Ramelyte E, Dummer R, Garzarolli M, Meier F, Meier E, Richly H, Gromke T, Siveke JT, Franklin C, Klespe KC, Mauch C, Kilian T, Seegräber M, Schilling B, French LE, Berking C, Heinzerling L. Tomsitz D, et al. Among authors: ramelyte e. Cancers (Basel). 2023 Jun 30;15(13):3430. doi: 10.3390/cancers15133430. Cancers (Basel). 2023. PMID: 37444540 Free PMC article.
37 results